In vivo transit dosimetry methodology for whole breast intensity modulated radiation therapy
Journal of Applied Clinical Medical Physics · 2025
DOI: 10.1002/acm2.70072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, 2025. Verfasst von Lucia Zirone und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical Physics Department, Humanitas Istituto Clinico Catanese, Misterbianco, Italy. Hauptthemen laut MEDLINE: Radiotherapy, Intensity-Modulated, Breast Neoplasms, Radiotherapy Planning, Computer-Assisted, Radiometry. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In vivo transit dosimetry using an electronic portal imaging device (EPID‐IVTD) is an important tool for verifying the accuracy of radiation therapy treatments. Despite its potential, the implementation of EPID‐IVTD in breast intensity modulated radiation therapy (IMRT) treatments has not yet been standardized, limiting its clinical adoption. A standardized EPID‐IVTD method could enhance treatment accuracy and improve patient safety in routine clinical practice.
Purpose
This study aims to develop a method for EPID‐IVTD for whole breast IMRT treatment.
Methods
Gamma passing rates (GPRs) analysis was the basis of the work conducted on a dataset of 50 patients. The first phase of the work focused on the identification of the reference fraction. In the second phase a method for performing EPID‐IVTD was implemented. Lower‐tolerance and ‐action limits (l‐TL and l‐AL), as introduced by AAPM TG 218, were employed to determine the reference fraction and used as alert and alarm thresholds, respectively, in EPID‐IVTD monitoring.
Results
The first treatment fraction demonstrated the best dosimetric agreement with the theoretical plan and was therefore used as the reference in the second phase of the study. EPID‐IVTD results showed that 75% of the GPRs ranged from 97.5% to 99.9%, 93.83% were above the l‐TL, 4.31% fell between l‐TL and l‐AL, and 1.86% were below l‐AL.
Conclusions
A method for the implementation of an effective EPID‐IVTD in whole breast IMRT treatment was developed and is now routinely applied at our center, enabling efficient monitoring in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Physics Department, Humanitas Istituto Clinico Catanese, Misterbianco, Italy.
- University of Catania, Department of Physics and Astronomy "Ettore Majorana", Catania, Italy.
- Radiotherapy Department, Humanitas Istituto Clinico Catanese, Misterbianco, Italy.
ORCID-Profile: Lucia Zirone, Giuseppina R Borzì, Alessia D'Anna, Martina Pace, Giuseppe Stella, Carmelo Marino
Zitieren
APA
Zirone, L., Bonanno, E., Borzì, G. R., Cavalli, N., D'Anna, A., Girlando, A., Pace, M., Stella, G., & Marino, C. (2025). In vivo transit dosimetry methodology for whole breast intensity modulated radiation therapy. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70072
Vancouver
Zirone L, Bonanno E, Borzì GR, Cavalli N, D'Anna A, Girlando A, et al. In vivo transit dosimetry methodology for whole breast intensity modulated radiation therapy. Journal of Applied Clinical Medical Physics. 2025. doi:10.1002/acm2.70072
BibTeX
@article{Zirone2025,
author = {Zirone, Lucia and Bonanno, Elisa and Borzì, Giuseppina R and Cavalli, Nina and D'Anna, Alessia and Girlando, Andrea and Pace, Martina and Stella, Giuseppe and Marino, Carmelo},
title = {In vivo transit dosimetry methodology for whole breast intensity modulated radiation therapy},
journal = {Journal of Applied Clinical Medical Physics},
year = {2025},
doi = {10.1002/acm2.70072}
}
EUVIMED